FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome

Blood Cancer Journal, Published online: 06 October 2020; doi:10.1038/s41408-020-00362-7FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome

http://feeds.nature.com/~r/bcj/rss/current/~3/31hn0Zho4Lw/s41408-020-00362-7

Source: Blood Cancer Journal - October 5, 2020 Category: Hematology Authors: Michael Schieber Christian Marinaccio Lyndsey C. Bolanos Wendy D. Haffey Kenneth D. Greis Daniel T. Starczynowski John D. Crispino Source Type: research

More News: Cancer | Cancer & Oncology | Hematology | Leukemia | Myelodysplastic Syndrome